Brief: Acrux Ltd Says Received FDA Approval For Generic Version Of Aczone Gel
27/08/2024 02:53
Aug 27 (Reuters) - Acrux Ltd ACR.AX :
* RECEIVES FDA APPROVAL FOR ITS GENERIC VERSION OF ACZONE
GEL,
7.5%
Further company coverage: ACR.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Acrux
See all newsBrief: Acrux Licenses Lenzetto For Australian Market For A$5.4 Million
Brief: Hungary's Richter and Acrux agree to license transdermal Estradiol spray for Australia
Brief: Acrux Says Capital Gains Tax Exemptions Remain In Place For Acrux
Australia's Acrux jumps on placement to fund female testosterone program
Brief: Acrux Raises A$1.6 Mln Via At 0.95 AU Cents Per Share